The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial-Reference-Cited by-同舟云学术

The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial

Published:2021-05-03 Issue:11 Volume:116 Page:3115-3126
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Santen Daniela K.¹²³^ORCID,Boyd Anders¹⁴^ORCID,Matser Amy¹,Maher Lisa⁵^ORCID,Hickman Matthew⁶^ORCID,Lodi Sara⁷,Prins Maria¹⁸

Affiliation:

1. Department of Infectious Diseases, Research and Prevention Public Health Service of Amsterdam Amsterdam the Netherlands

2. Department of Disease Elimination Burnet Institute Melbourne VIC Australia

3. Department of Epidemiology and Preventive Medicine Monash University Melbourne VIC Australia

4. Stichting HIV Monitoring Amsterdam the Netherlands

5. The Kirby Institute for Infection and Immunity, Faculty of Medicine UNSW Sydney Sydney NSW Australia

6. Population Health Sciences, Bristol Medical School University of Bristol Bristol UK

7. Department of Biostatistics Boston University School of Public Health Boston MA USA

8. Department of Infectious Diseases, Amsterdam Infection and Immunity Institute (AIandII), Amsterdam UMC University of Amsterdam Amsterdam the Netherlands

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15503

Reference42 articles.

1. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

2. GradyB.Hepatitis C Virus: Risk Factors and Disease Progression PhD thesis. Ede the Netherlands: University of Amsterdam; 2015.

3. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

4. The 'methadone by bus' project in Amsterdam

5. Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterising the effectiveness of social determinants of health-focused hepatitis B interventions: a systematic review;The Lancet Infectious Diseases;2024-06

2. Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study;International Journal of Drug Policy;2024-05

3. A systematic meta-epidemiologic review on nonabstinence-inclusive interventions for substance use: inclusion of race/ethnicity and sex assigned at birth/gender;The American Journal of Drug and Alcohol Abuse;2024-02-27

4. “No-one just does drugs during business hours!”: evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia;Harm Reduction Journal;2024-02-24

5. Hepatitis B Virus Elimination Strategies;Current Hepatology Reports;2024-02-21